Współczesna Onkologia

Artificial intelligence-driven body composition analysis and its association with survival in patients with colorectal liver metastases

Miłosz Rozynek 1
,
Zbisław Tabor 2
,
Stanisław Kłęk 3
,
Tadeusz Popiela 1
,
Wadim Wojciechowski 1

  1. Department of Radiology, Jagiellonian University Medical College, Cracow, Poland

  2. Department of Biocybernetics and Biomedical Engineering, AGH University, Cracow, Poland

  3. Surgical Oncology Clinic, Maria Sklodowska-Curie National Cancer Institute, Cracow, Poland

Contemp Oncol (Pozn) 2026; 30 (2)

DOI: https://doi.org/10.5114/wo.2026.163047
Data publikacji online: 2026/07/06
Article file
Artificial intelligence-driven.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Ivey GD, Johnston FM, Azad NS, Christenson ES, Lafaro KJ, Shu- bert CR. Current surgical management strategies for colorectal cancer liver metastases. Cancers (Basel) 2022; 14: 1063.
  2. Tian Y, Wang Y, Wen N, Wang S, Li B, Liu G. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis. BMC Cancer 2024; 24: 1-18.
  3. Brown JC, Feliciano EMC, Caan BJ. The evolution of body composition in oncology – epidemiology, clinical trials, and the future of patient care: facts and numbers. J Cachexia Sarcopenia Muscle 2018; 9: 1200-1208.
  4. Bradshaw PT. Body composition and cancer survival: a narrative review. Br J Cancer 2023; 130: 176-183.
  5. Tamandl Di, Mang T, Ba-Ssalamah A. Imaging of colorectal cancer – the clue to individualized treatment. Innov Surg Sci 2018; 3: 3.
  6. Elhakim T, Trinh K, Mansur A, Bridge C, Daye D. Role of machine learning- based CT body composition in risk prediction and prognostication: current state and future directions. Diagnostics 2023; 13: 968.
  7. Da Silva Nascimento ML, Alves Bennemann N, de Sousa IM, de Oliveira Bezerra MR, Villaça Chaves G, Moreira Lima Verde SM, et al. Examining variations in body composition among patients with colorectal cancer according to site and disease stage. Sci Rep 2024; 14: 1-9.
  8. Miranda AL, da Costa Pereira JP, de Sousa IM, Ferreira GMC, de Oliveira Bezerra MR, Chaves GV, et al. Impact of body composition and muscle health phenotypes on survival outcomes in colorectal cancer: a multicenter cohort. Sci Rep 2024; 14: 1-10.
  9. Ma M, Luo M, Liu Q, Zhong D, Liu Y, Zhang K. Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: a retrospective cohort study. J Cancer Res Clin Oncol 2024; 150: 1-13.
  10. Crudele L, Piccinin E, Moschetta A. Visceral adiposity and cancer: role in pathogenesis and prognosis. Nutrients 2021; 13: 2101.
  11. Mai DVC, Drami I, Pring ET, Gould LE, Lung P, Popuri K, et al. A systematic review of automated segmentation of 3D computed-tomography scans for volumetric body composition analysis. J Cachexia Sarcopenia Muscle 2023; 14: 1973-1986.
  12. Koitka S, Kroll L, Malamutmann E, Oezcelik A, Nensa F. Fully automated body composition analysis in routine CT imaging using 3D semantic segmentation convolutional neural networks. Eur Radiol 2021; 31: 1795-1804.
  13. Van Helsdingen CPM, van Wijlick JGA, de Vries R, Bouvy ND, Leeflang MMG, Hemke R, et al. Association of computed tomography- derived body composition and complications after colorectal cancer surgery: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2024; 15.
  14. Keyl J, Hosch R, Berger A, Ester O, Greiner T, Bogner S, et al. Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer. J Cachexia Sarcopenia Muscle 2022; 14: 545.
  15. Shiozawa T, Kikuchi Y, Wakabayashi T, Matsuo K, Takahashi Y, Tanaka K. Body composition as reflected by intramuscular adipose tissue content may influence short- and long-term outcome following 2-stage liver resection for colorectal liver metastases. Langenbecks Arch Surg 2020; 405: 757-766.
  16. Drami I, Pring ET, Gould L, Malietzis G, Naghibi M, Athanasiou T, et al. Body composition and dose-limiting toxicity in colorectal cancer chemotherapy treatment; a systematic review of the literature. Could muscle mass be the new body surface area in chemotherapy dosing? Clin Oncol (R Coll Radiol) 2021; 33: e540-552.
  17. Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, et al. The cancer imaging archive (TCIA): maintaining and operating a public information repository. J Digit Imaging 2013; 26: 1045-1057.
  18. Simpson AL, Peoples J, Creasy JM, Fichtinger G, Gangai N, Keshavamurthy KN, et al. Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases. Sci Data 2024; 11.
  19. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washin- gton MK, et al. AJCC Cancer Staging Manual. 8th ed. Springer 2017.
  20. Bradski G. The OpenCV Library. Dr Dobb’s Journal of Software Tools 2000.
  21. Brett M, Markiewicz CJ, Hanke M, Côté M-A, Cipollini B, Papadopoulos Orfanos D, et al. nipy/nibabel: 5.3.0 2024. Available from: https://doi.org/10.5281/zenodo.13905405.
  22. Mason D, scaramallion, mrbean-bremen, rhaxton, Suever J, Orfanos DP, et al. pydicom/pydicom: pydicom 3.0.1 2024. Available from: https://doi.org/10.5281/zenodo.13824606.
  23. Rozynek M, Tabor Z, Kłęk S, Wojciechowski W. Body composition radiomics features as a predictor of survival in non-small-cell lung carcinoma patients: a multicenter retrospective study. Nutrition 2023: 112336.
  24. Rozynek M, Gut D, Kucybała I, Strzałkowska-Kominiak E, Tabor Z, Urbanik A, et al. Fully automated 3D body composition analysis and its association with overall survival in head and neck squamous cell carcinoma patients. Front Oncol 2023; 13.
  25. Cardoso MJ, Li W, Brown R, Ma N, Kerfoot E, Wang Y, et al. MONAI: an open-source framework for deep learning in healthcare n.d. Available from: https://doi.org/10.48550/arXiv.2211.02701.
  26. Isensee F, Petersen J, Klein A, Zimmerer D, Jaeger PF, Kohl S, et al. nnU-Net: Self-adapting Framework for U-Net-Based Medical Image Segmentation. Informatik Aktuell 2018: 22.
  27. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 2020; 17: 261-272.
  28. R Core Team. R: A Language and Environment for Statistical Computing 2021.
  29. Dolan DR, Knight KA, Maguire S, Moug SJ. The relationship between sarcopenia and survival at 1 year in patients having elective colorectal cancer surgery. Tech Coloproctol 2019; 23: 877-885.
  30. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931-936.
  31. Lee CS, Won DD, Oh SN, Lee YS, Lee IK, Kim IH, et al. Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World J Surg Oncol 2020; 18.
  32. Golder AM, Ferguson M, McMillan P, Mansouri D, Horgan PG, Roxburgh CS, et al. CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer. Sci Rep 2024; 14.
  33. Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, et al. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 2020; 46: 1656-1662.
  34. Golder AM, Sin LKE, Alani F, Alasadi A, Dolan R, Mansouri D, et al. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer. J Cachexia Sarcopenia Muscle 2022; 13: 2863-2874.
  35. Kim M, Lee SM, Son IT, Park T, Oh BY. Prognostic value of artificial intelligence-driven, computed tomography-based, volumetric assessment of the volume and density of muscle in patients with colon cancer. Korean J Radiol 2023; 24: 849-859.
  36. Cheng E, Caan BJ, Cawthon PM, Evans WJ, Hellerstein MK, Shankaran M, et al. Body composition, relative dose intensity, and adverse events among patients with colon cancer. Cancer Epidemiol Biomarkers Prev 2023; 32: 1373-1381.
  37. Looijaard WGPM, Dekker IM, Stapel SN, Girbes ARJ, Twisk JWR, Oudemans-van Straaten HM, et al. Skeletal muscle quality as assessed by CT-derived skeletal muscle density is associated with 6-month mortality in mechanically ventilated critically ill patients. Crit Care 2016; 20: 386.
  38. Lavalle S, Rosaria Valerio M, Masiello E, Gebbia V, Scandurra G. Unveiling the intricate dance: how cancer orchestrates muscle wasting and sarcopenia n.d. Available from: https://doi.org/10.21873/invivo.13602.
  39. Fleming CA, O’Connell EP, Kavanagh RG, O’Leary DP, Twomey M, Corrigan MA, et al. Body composition, inflammation, and 5-year outcomes in colon cancer. JAMA Netw Open 2021; 4.
  40. He Q, Xia B, Liu A, Li M, Zhou Z, Cheung EC, et al. Association of body composition with risk of overall and site-specific cancers: a population-based prospective cohort study. Int J Cancer 2021; 149: 1435-1447.
  41. Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study). Cancer Epidemiol Biomarkers Prev 2017; 26: 1008.
  42. Yamada S, Morine Y, Ikemoto T, Saito Y, Miyazaki K, Shimizu M, et al. Inhibitory effect of non-alcoholic steatohepatitis on colon cancer liver metastasis. Eur J Surg Oncol 2023; 49: 410-415.
  43. Lv Y, Zhang HJ. Effect of non-alcoholic fatty liver disease on the risk of synchronous liver metastasis: analysis of 451 consecutive patients of newly diagnosed colorectal cancer. Front Oncol 2020; 10: 251.
  44. Meunier L, Larrey D. Chemotherapy-associated steatohepatitis. Ann Hepatol 2020; 19: 597-601.
  45. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
  46. Cao K, Yeung J, Arafat Y, Choi CS, Wei MYK, Chan S, et al. Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy? J Cancer Res Clin Oncol 2023; 149: 13915-13923.
  47. Klassen P, Baracos V, Gramlich L, Nelson G, Mazurak V, Martin L. Computed-tomography body composition analysis complements pre-operative nutrition screening in colorectal cancer patients on an enhanced recovery after surgery pathway. Nutrients 2020; 12: 1-12.
  48. Holmes CJ, Racette SB. The utility of body composition assessment in nutrition and clinical practice: an overview of current methodology. Nutrients 2021; 13: 2493.
  49. Duren DL, Sherwood RJ, Czerwinski SA, Lee M, Choh AC, Siervo- gel RM, et al. Body composition methods: comparisons and interpretation. J Diab Sci Technol 2008; 2: 1139.
  50. Caruso D, Polici M, Bellini D, Laghi A. ESR essentials: imaging in colorectal cancer – practice recommendations by ESGAR. Eur Radiol 2024; 34: 5903.
  51. Lever J, Krzywinski M, Altman N. Points of significance: model selection and overfitting. Nat Methods 2016; 13: 703-704.
  52. Attanasio S, Forte SM, Restante G, Gabelloni M, Guglielmi G, Neri E. Artificial intelligence, radiomics and other horizons in body composition assessment. Quant Imaging Med Surg 2020; 10: 1650.
  53. Wu H, Yu D, Li J, He X, Li C, Li S, et al. Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy. Gland Surg 2024; 13: 1588-1604.
  54. Saalfeld S, Kreher R, Hille G, Niemann U, Hinnerichs M, Öcal O, et al. Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients. J Cachexia Sarcopenia Muscle 2023; 14: 2301-2309.
  55. Zhong J, Liu X, Lu J, Yang J, Zhang G, Mao S, et al. Overlooked and underpowered: a meta-research addressing sample size in radiomics prediction models for binary outcomes. Eur Radiol 2025; 35: 1146-1156.
  56. Wimmer K, Schwarz C, Szabo C, Bodingbauer M, Tamandl D, Mittlböck M, et al. Impact of neoadjuvant chemotherapy on clinical risk scores and survival in patients with colorectal liver metastases. Ann Surg Oncol 2017; 24: 236-243.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications